The role of pharmacogenomics in epilepsy treatment: advancements in personalized medicine.
- DOI
- 10.1038/s41397-026-00430-4
- Published
- 2026 Oct 1
- Container
- The pharmacogenomics journal
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41397-026-00430-4,
title = {The role of pharmacogenomics in epilepsy treatment: advancements in personalized medicine.},
author = {Ahangari N and Doosti M and Safi M and Hashemi N and Imannezhad S and Barazandeh B and Ghayoor Karimiani E and Beiraghi Toosi M},
year = {2026},
journal = {The pharmacogenomics journal},
doi = {10.1038/s41397-026-00430-4},
url = {https://doi.org/10.1038/s41397-026-00430-4}
}RIS
TY - JOUR TI - The role of pharmacogenomics in epilepsy treatment: advancements in personalized medicine. AU - Ahangari N AU - Doosti M AU - Safi M AU - Hashemi N AU - Imannezhad S AU - Barazandeh B AU - Ghayoor Karimiani E AU - Beiraghi Toosi M PY - 2026 JO - The pharmacogenomics journal DO - 10.1038/s41397-026-00430-4 UR - https://doi.org/10.1038/s41397-026-00430-4 ER -
APA
N, A., M, D., M, S., N, H., S, I., B, B., E, G. K., & M, B. T. (2026). The role of pharmacogenomics in epilepsy treatment: advancements in personalized medicine.. The pharmacogenomics journal. https://doi.org/10.1038/s41397-026-00430-4
Source records
- pubmed · retrieved 2026-11-10T12:20:08.218Z